TherapeuticsMD, Inc. Reaffirms Revenue Guidance for the Fourth Quarter of 2019
November 06, 2019 at 04:05 pm EST
TherapeuticsMD, Inc. reaffirmed revenue guidance for the fourth quarter of 2019. For the quarter, FDA-approved product net revenue is expected to be in a range of $11 million to $13 million; Prescription prenatal vitamin net revenue is expected to be in a range of $1.75 million to $2.25 million; and total product net revenue is expected to be in a range of $12.75 million to $15.25 million.